Anton M. Bennett

Anton M. Bennett

Yale University

H-index: 45

North America-United States

About Anton M. Bennett

Anton M. Bennett, With an exceptional h-index of 45 and a recent h-index of 26 (since 2020), a distinguished researcher at Yale University, specializes in the field of Signal transduction, protein phosphorylation, metabolism, rare diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Hepatocyte-specific mitogen-activated protein kinase phosphatase 1 in sexual dimorphism and susceptibility to alcohol induced liver injury

Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α

The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy

MAP kinase phosphatase-1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution

Hepatocyte-specific miR-33 deletion attenuates NAFLD-NASH-HCC progression

Compounds and Compositions for Treating Fibrosis

Mitogen-activated protein kinase phosphatases: No longer undruggable?

Map Kinase Phosphatase-5 Deficiency Impairs Efferocytosis And Exacerbates Late-Stage Atherosclerosis

Anton M. Bennett Information

University

Position

Professor of Pharmacology School of Medicine

Citations(all)

9331

Citations(since 2020)

2563

Cited By

8081

hIndex(all)

45

hIndex(since 2020)

26

i10Index(all)

67

i10Index(since 2020)

51

Email

University Profile Page

Google Scholar

Anton M. Bennett Skills & Research Interests

Signal transduction

protein phosphorylation

metabolism

rare diseases

Top articles of Anton M. Bennett

Title

Journal

Author(s)

Publication Date

Hepatocyte-specific mitogen-activated protein kinase phosphatase 1 in sexual dimorphism and susceptibility to alcohol induced liver injury

Frontiers in Immunology

Mary Nancy Walter

Diego Montoya-Durango

Walter Rodriguez

Yali Wang

JingWen Zhang

...

2024/2/1

Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α

Diabetologia

Beibei Liu

Di Xie

Xinmei Huang

Sungho Jin

Yangyang Dai

...

2024/1/13

The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy

Elizabeth I Pierpont

Anton M Bennett

Lisa Schoyer

Beth Stronach

April Anschutz

...

2024/4

MAP kinase phosphatase-1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution

The Journal of Clinical Investigation

Sean M Fortier

Natalie M Walker

Loka R Penke

Jared D Baas

Qinxue Shen

...

2024/3/21

Hepatocyte-specific miR-33 deletion attenuates NAFLD-NASH-HCC progression

bioRxiv

Pablo Fernández-Tussy

Jonathan Sun

Magdalena P Cardelo

Nathan L Price

Leigh Goedeke

...

2023/1/20

Compounds and Compositions for Treating Fibrosis

2023/6/15

Mitogen-activated protein kinase phosphatases: No longer undruggable?

Shanelle R Shillingford

Anton M Bennett

2023/1/20

Map Kinase Phosphatase-5 Deficiency Impairs Efferocytosis And Exacerbates Late-Stage Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Margaret Baldini

Masahi Azuma

Andrea Palos-Jasso

Dan Shan

Rajika Roy

...

2023/5

MAP Kinase Phosphatases as Nodal Signal Regulators in Health and Disease

Journal of Biological Chemistry

Anton Bennett

2023/1/1

Identification of Protein Tyrosine Phosphatase (PTP) Substrates

Sravan Perla

Bin Qiu

Sam Dorry

Jae-Sung Yi

Anton M Bennett

2023/12/27

Teaching an old dog new tricks: A new tool for protein tyrosine phosphatase substrate discovery

Journal of Biological Chemistry

Anton M Bennett

2023/5/1

An assessment of the therapeutic landscape for the treatment of heart disease in the RASopathies

Jae-Sung Yi

Sravan Perla

Anton M Bennett

2023/12

SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts

Diagnostics

Theodoros Karampitsakos

Apostolos Galaris

Ilianna Barbayianni

Giuseppe DeIuliis

Farida Ahangari

...

2023/3/18

MKP1 promotes nonalcoholic steatohepatitis by suppressing AMPK activity through LKB1 nuclear retention

Nature Communications

Bin Qiu

Ahmed Lawan

Chrysovalantou E Xirouchaki

Jae-Sung Yi

Marie Robert

...

2023/9/5

Compositions and methods of using tyrosine kinase inhibitors

2023/2/2

ROLE OF MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASE 1 (MKP1) IN ALCOHOL-INDUCED LIVER INJURY

Gen Sheng Wu

2007/12

The seventh international RASopathies symposium: Pathways to a cure—expanding knowledge, enhancing research, and therapeutic discovery

Maria I Kontaridis

Amy E Roberts

Lisa Schill

Lisa Schoyer

Beth Stronach

...

2022/6

Lack Of Map Kinase Phosphatase-5 In Macrophages Protects Ldlr-null Mice Against Atherogenesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Xinbo Zhang

Zhiqiang Zhao

Margaret Baldini

Cheng Zhang

Bo Tao

...

2022/5

Defining the structure-activity relationship for a novel class of allosteric MKP5 inhibitors

European Journal of Medicinal Chemistry

Zira TK Gannam

Haya Jamali

Oh Sang Kweon

James Herrington

Shanelle R Shillingford

...

2022/12/5

Compounds, compositions, and methods for treating fibrosis

2022/3/31

See List of Professors in Anton M. Bennett University(Yale University)

Co-Authors

academic-engine